ecrin-mdr-crcClinical2020IPD Sharing (as of May 2023): NoThrombocytopeniaAppendix CancerAmpullary CancerColorectal CancerGastric CancerEsophageal CancerSmall Bowel CancerAppendiceal NeoplasmsThrombocytopeniaAppendix CancerAmpullary CancerColorectal CancerGastric CancerEsophageal CancerSmall Bowel CancerAppendiceal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2349870United States10Dose adjustmentFOLFOXNeutropeniaECRIN MDRCompletedfalseClinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX ChemotherapyThe study is testing an intervention of an investigator-developed chemotherapy dose adjustment algorithm. The primary objective of this study is to evaluate the effectiveness of the chemotherapy dose adjustment algorithm for reducing unplanned delays in patients receiving FOLFOX (5-fluorouracil, leucovorin, and oxaliplatin)-type chemotherapy, while maintaining acceptable chemotherapy dose-intensity.2020-10-152349870NCT04526886